认知障碍与老年非ST段抬高型急性冠脉综合征患者的预后
本研究纳入239例≥75岁接受侵入性治疗的非ST段抬高型急性冠脉综合征(NSTEACS)患者,用蒙特利尔认知评估基线认知状态,随访5年。认知障碍组与正常认知组主要不良心血管事件(MACE)发生率无显著差异,但认知障碍与全因死亡风险升高独立相关(aHR 1.85,95%CI 1.11-3.08;p=0.018)。
要点
- 认知障碍未显著增加NSTEACS老年患者5年MACE风险(p=0.155)。
- 认知障碍与全因死亡风险升高独立相关(aHR 1.85,95%CI 1.11-3.08)。
- 常规认知筛查可能有助于该人群的风险分层。
核心结论
- 在接受侵入性策略的老年NSTEACS患者中,认知障碍与长期全因死亡率升高相关,但与MACE复合终点无显著关联。
研究设计与样本
- 多中心前瞻性研究(NCT01933581),纳入239例≥75岁接受侵入性治疗的NSTEACS患者,基线用蒙特利尔认知评估(≥26分为正常,<26分为认知障碍),随访5年。
主要发现
- 5年随访时,认知障碍组与正常认知组MACE发生率无显著差异(p=0.155)。
- 认知状态与MACE无显著关联(HR 1.37,95%CI 0.96-1.95;p=0.082)。
- 认知障碍组死亡显著增多(p=0.005)。
- Kaplan-Meier分析(log-rank p=0.003)和Cox回归(aHR 1.85,95%CI 1.11-3.08;p=0.018)显示全因死亡风险升高,校正衰弱和GRACE评分后仍显著。
关键数值与推荐
- 蒙特利尔认知评估评分≥26分为正常,<26分为认知障碍。
- 主要终点MACE为全因死亡、再发心梗、卒中/短暂性脑缺血发作、紧急血运重建和显著出血的复合终点。
临床怎么用
- 对老年NSTEACS患者可考虑常规认知筛查以辅助风险分层。
- 认知障碍患者应加强死亡风险评估与个体化管理决策。
局限性
- 样本量较小(239例),仅纳入接受侵入性治疗的患者。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to explore the prognostic impact of cognitive impairment on the long-term risk of major adverse cardiovascular events (MACEs) in older patients with non-ST-elevation acute coronary syndrome (NSTEACS) undergoing invasive treatment. METHODS: Patients aged ≥75 years with NSTEACS undergoing an invasive strategy were included in the multicentre prospective study (NCT01933581). Montreal Cognitive Assessment was used to evaluate cognitive status at baseline (scores ≥26 classified as normal, <26 as cognitive impairment). Long-term follow-up data were obtained from electronic patient care records. The primary endpoint was MACE as a composite of all-cause deaths, reinfarction, stroke/transient ischaemic attack, urgent revascularisation and significant bleeding. RESULTS: 239 patients with baseline cognitive assessment completed long-term follow-up. Median age was 80.9 years (IQR 78.2-83.9 years) and 62.3% were male. On 5-year follow-up, there was no significant difference in the occurrence of MACE between the cognitively impaired group and the normal cognition group (p=0.155). Cognition status was not associated with MACE (HR 1.37 (95% CI 0.96 to 1.95); p=0.082). However, there was significantly more deaths (p=0.005) in those with cognitive impairment. Kaplan-Meier survival analysis (log-rank p=0.003) and Cox regression analysis (aHR 1.85 (95% CI 1.11 to 3.08); p=0.018) revealed increased risk of all-cause mortality, even after adjusting for frailty and GRACE (Global Registry of Acute Coronary Events) score. CONCLUSION: Cognitive impairment in older patients with NSTEACS undergoing an invasive strategy was associated with long-term all-cause mortality. Routine cognitive screening may aid risk stratification and further studies are needed to identify how this should influence management strategies and individual decision-making in this patient group. TRIAL REGISTRATION NUMBER: NCT01933581.
引用
- Dirjayanto, Alkhalil, Dodson, et al. Cognitive impairment and outcomes in older adults with non-ST-elevation acute coronary syndrome. Heart. 2024. PMID: 37813562. doi:10.1136/heartjnl-2023-323224
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。